ジストニア治療薬の世界市場は、2021年に約8億670万米ドルと評価され、予測期間の2022年から2029年には5.5%以上の健全な成長率で成長すると予測されています。ジストニアは、ゆっくりとした反復運動や異常な姿勢を引き起こす不随意筋収縮を特徴とする運動障害として分類される場合があります。これらの筋収縮は、異常な体の姿勢や動きを引き起こします。ジストニアの種類によって、1つの筋肉、複数の筋肉、または全身の筋肉が影響を受ける場合があります。ジストニアは、出生に伴う脳損傷、特定の感染症、脳外傷、脳卒中や動静脈などの血管の異常などの障害によって引き起こされ、患者の動作が不快になったり、震えが生じたりすることがあります。ジストニアには特定の治療法はありませんが、いくつかの薬剤はその症状を和らげるのに役立ちます。ジストニア治療薬市場の拡大は、医療インフラの強化、未充足の医療需要の増加、高度な医療施設に対する需要の増加により、未開拓の新興市場の著しい拡大によってもたらされると予想されます。ジストニアの発生率と、ジストニアに類似した症状を持つ他の神経疾患の有病率の両方が上昇しているため、市場は拡大しています。ジストニア治療薬の市場は、先進国と新興国の両方で研究開発活動が活発化していることも拡大の背景となっています。様々な医学的疾患の治療のための新薬の開発・発明に対する研究者の努力は、著しく高まっています。現在、高活性の新薬分子の開発が主な研究分野となっています。薬物開発の革新は、強力なジストニア治療薬の提供にも利用されています。このように、この研究の高まりがジストニア治療薬の市場を後押ししています。
National Organization for Rare Disorders, Inc.（NORD）によると、2020年には、異なるタイプのジストニアに罹患している北アメリカの人が30万人いたと述べています。ジストニアの有病率は増加しており、そのため治療薬のニーズが高まり、ジストニア治療薬の市場シェア拡大の原動力となっています。また、ヘルスケア分野への投資の増加や、政府の結束した支援は、市場に有利な機会をもたらすと予想されています。しかし、ジストニアに関する認知度の低さが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。
世界のジストニア治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、主要な市場プレイヤーの存在、ジストニアの増加、ジストニアを引き起こす他の神経学的疾患の有病率の上昇により、市場シェアにおいて世界の主要な地域となっています。一方、アジア太平洋地域は、産業基盤の整備や可処分所得の増加、国内企業の定着などの要因により、予測期間中に最も高い成長率を示すと予想されており、アジア太平洋地域のジストニア治療薬市場に有利な成長見通しをもたらすと考えられます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Dystonia Drugs Market, by Region, 2019-2029 (USD Million)
1.2.2. Dystonia Drugs Market, by Drug Type, 2019-2029 (USD Million)
1.2.3. Dystonia Drugs Market, by Route of Administration, 2019-2029 (USD Million)
1.2.4. Dystonia Drugs Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Estimation Methodology
1.4. Research Assumption
Chapter 2. Global Dystonia Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dystonia Drugs Market Dynamics
3.1. Dystonia Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rise in incidences of dystonia
3.1.1.2. Increasing R&D activities in pharmaceutical field
3.1.2. Market Challenges
3.1.2.1. Lack of awareness about dystonia in underdeveloped nations
3.1.3. Market Opportunities
3.1.3.1. Rising investment in healthcare sector
3.1.3.2. Cohesive government support
Chapter 4. Global Dystonia Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Dystonia Drugs Market, by Drug Type
6.1. Market Snapshot
6.2. Global Dystonia Drugs Market by Drug Type, Performance - Potential Analysis
6.3. Global Dystonia Drugs Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
6.4. Dystonia Drugs Market, Sub Segment Analysis
6.4.1. Anticonvulsants drugs
6.4.2. Dopaminergic agents
6.4.3. GABAergic agents
6.4.4. Others
Chapter 7. Global Dystonia Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Dystonia Drugs Market by Route of Administration, Performance - Potential Analysis
7.3. Global Dystonia Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
7.4. Dystonia Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Injectable
Chapter 8. Global Dystonia Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Dystonia Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Dystonia Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Dystonia Drugs Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Online Providers
8.4.3. Drug Stores and Retail Pharmacies
Chapter 9. Global Dystonia Drugs Market, Regional Analysis
9.1. Dystonia Drugs Market, Regional Market Snapshot
9.2. North America Dystonia Drugs Market
9.2.1. U.S. Dystonia Drugs Market
9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Dystonia Drugs Market
9.3. Europe Dystonia Drugs Market Snapshot
9.3.1. U.K. Dystonia Drugs Market
9.3.2. Germany Dystonia Drugs Market
9.3.3. France Dystonia Drugs Market
9.3.4. Spain Dystonia Drugs Market
9.3.5. Italy Dystonia Drugs Market
9.3.6. Rest of Europe Dystonia Drugs Market
9.4. Asia-Pacific Dystonia Drugs Market Snapshot
9.4.1. China Dystonia Drugs Market
9.4.2. India Dystonia Drugs Market
9.4.3. Japan Dystonia Drugs Market
9.4.4. Australia Dystonia Drugs Market
9.4.5. South Korea Dystonia Drugs Market
9.4.6. Rest of Asia Pacific Dystonia Drugs Market
9.5. Latin America Dystonia Drugs Market Snapshot
9.5.1. Brazil Dystonia Drugs Market
9.5.2. Mexico Dystonia Drugs Market
9.5.3. Rest of Latin America Dystonia Drugs Market
9.6. Rest of The World Dystonia Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novartis AG
10.2.3. Sanofi
10.2.4. Merck & Co, Inc
10.2.5. Aspan Holdings
10.2.6. China Shineway Pharmaceutical Group Limited
10.2.7. Boston Scientific Corporation
10.2.8. Ipsen Pharma
10.2.9. Revance therapeutics Inc
10.2.10. Merz Pharma
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Dystonia Drugs Market, report scope
TABLE 2. Global Dystonia Drugs Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Dystonia Drugs Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
TABLE 4. Global Dystonia Drugs Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
TABLE 5. Global Dystonia Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
TABLE 6. Global Dystonia Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Dystonia Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Dystonia Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Dystonia Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Dystonia Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Dystonia Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Dystonia Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Dystonia Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Dystonia Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Dystonia Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. U.S. Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. Canada Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 20. Canada Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. Canada Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. UK Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 23. UK Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. UK Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. Germany Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 26. Germany Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. Germany Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. France Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 29. France Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. France Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. Italy Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 32. Italy Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Italy Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Spain Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 35. Spain Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. Spain Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. RoE Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 38. RoE Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. RoE Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. China Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 41. China Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. China Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. India Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 44. India Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. India Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. Japan Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 47. Japan Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. Japan Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. South Korea Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 50. South Korea Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. South Korea Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. Australia Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 53. Australia Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. Australia Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. RoAPAC Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 56. RoAPAC Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. RoAPAC Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. Brazil Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 59. Brazil Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Brazil Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Mexico Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 62. Mexico Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. Mexico Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. RoLA Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 65. RoLA Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. RoLA Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. Row Dystonia Drugs Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 68. Row Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. Row Dystonia Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Dystonia Drugs Market
TABLE 71. List of primary sources, used in the study of global Dystonia Drugs Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Dystonia Drugs Market, research methodology
FIG 2. Global Dystonia Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Dystonia Drugs Market, key trends 2021
FIG 5. Global Dystonia Drugs Market, growth prospects 2022-2029
FIG 6. Global Dystonia Drugs Market, porters 5 force model
FIG 7. Global Dystonia Drugs Market, pest analysis
FIG 8. Global Dystonia Drugs Market, value chain analysis
FIG 9. Global Dystonia Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Dystonia Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Dystonia Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Dystonia Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Dystonia Drugs Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Dystonia Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Dystonia Drugs Market 2019 & 2029 (USD Million)
FIG 16. Europe Dystonia Drugs Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Dystonia Drugs Market 2019 & 2029 (USD Million)
FIG 18. Latin America Dystonia Drugs Market 2019 & 2029 (USD Million)
FIG 19. Global Dystonia Drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
